AI Analysis AI Analysis of BCDA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BCDA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in BioCardia, Inc. stock price on Friday which ended trading at $0.88
(Updated on Jun 12, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 08, 2026 Loss -4.35%

The BioCardia, Inc. stock price gained 10.68% on the last trading day (Friday, 12th Jun 2026), rising from $0.795 to $0.88. During the last trading day the stock fluctuated 13.11% from a day low at $0.795 to a day high of $0.90. The price has fallen in 7 of the last 10 days and is down by -5.38% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 326 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $984.58 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.76% during the next 3 months and, with a 90% probability hold a price between $0.562 and $0.716 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BCDA Signals & Forecast

There are mixed signals in the stock today. The BioCardia, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.89 and $1.00. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Thursday, June 11, 2026, and so far it has risen 10.68%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioCardia, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for BioCardia, Inc. stock

BioCardia, Inc. finds support from accumulated volume at $0.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.104 between high and low, or 13.11%. For the last week, the stock has had daily average volatility of 13.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCDA) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect BioCardia, Inc. to open at $0.86, and during the day (based on 14 day Average True Range), to move between $0.82 and $0.94, which gives a possible trading interval of +/-$0.116 (+/-14.15%) up or down from last closing price. If BioCardia, Inc. takes out the full calculated possible swing range there will be an estimated 14.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.86 (2.31%) than the resistance at $0.92 (4.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioCardia, Inc. stock A Buy?

BioCardia, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.051 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $0.86 ( 2.49%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BCDA Performance

Trading levels for BCDA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.96 9.35%
R2 0.92 4.83%
R1 0.90 2.03%
Price 0.88
S1 0.82 -7.02%
S2 0.794 -9.81%
S3 0.754 -14.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.03 17.05%
R2 1.01 14.77%
R1 0.92 4.55%
Price 0.88
S1 0.86 -2.31%
S2 0.81 -7.95%
S3 0.795 -9.65%

FAQ

What is the symbol for BioCardia, Inc. Stock and on which exchange is it traded?
The symbol for BioCardia, Inc. is BCDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioCardia, Inc. Stock?
BioCardia, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy BioCardia, Inc. Stock?
BioCardia, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioCardia, Inc. Stock.

What's the current price of BioCardia, Inc. Stock?
As of the end of day on the Jun 12, 2026, the price of an BioCardia, Inc. (BCDA) share was $0.88.

What is the 52-week high and low for BioCardia, Inc. Stock?
The 52-week high for BioCardia, Inc. Stock is $2.45 and the 52-week low is $0.777.

What is the market capitalization of BioCardia, Inc. Stock?
As of the Jun 12, 2026, the market capitalization of BioCardia, Inc. is 5.103M.

When is the next earnings date for BioCardia, Inc.?
The upcoming earnings date for BioCardia, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOCARDIA, INC.
BioCardia
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE